Stay updated on Phase 1 Study CI-8993 Anti-VISTA Antibody Clinical Trial

Sign up to get notified when there's something new on the Phase 1 Study CI-8993 Anti-VISTA Antibody Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Phase 1 Study CI-8993 Anti-VISTA Antibody Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    Website version updated from v3.4.3 to v3.5.0. No study content or user-facing details were altered.
    Difference
    0.1%
    Check dated 2026-03-20T19:55:53.000Z thumbnail image
  4. Check
    23 days ago
    No Change Detected
  5. Check
    30 days ago
    Change Detected
    Summary
    Revision tag updated from v3.4.2 to v3.4.3. This appears to be a minor site update with no changes to study content.
    Difference
    0.1%
    Check dated 2026-03-06T18:11:18.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    Revision updated: v3.4.2 added; v3.4.1 removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-13T12:32:34.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Summary
    Revision updated from v3.4.0 to v3.4.1; no substantive changes to study details or page interactions are evident. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-06T09:12:00.000Z thumbnail image
  8. Check
    81 days ago
    Change Detected
    Summary
    Revision updated from v3.3.3 to v3.3.4. This appears to be a backend/versioning update that does not alter study information or navigation.
    Difference
    0.1%
    Check dated 2026-01-15T04:28:03.000Z thumbnail image
  9. Check
    102 days ago
    Change Detected
    Summary
    Locations were updated: New Hampshire, New York, Tennessee, Texas, and Victoria were added and prior location entries removed; the HHS Vulnerability Disclosure link was removed (Revision: v3.3.3).
    Difference
    0.7%
    Check dated 2025-12-24T13:52:30.000Z thumbnail image

Stay in the know with updates to Phase 1 Study CI-8993 Anti-VISTA Antibody Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Phase 1 Study CI-8993 Anti-VISTA Antibody Clinical Trial page.